Background and Purpose: The hospital-based stroke registry is a well-established method useful for understanding diverse clinical characteristics of stroke related to geographical, racial or environmental differences. We analyzed the data from 1,000 patients with acute cerebral infarctions registered with the Yonsei Stroke Registry (YSR) which is the first prospective hospital-based observational study in Korea. Methods: All patients had cerebral infarctions and presented within 7 days of onset. CT or MRI was performed in all patients and a vascular imaging study (digital subtraction or magnetic resonance angiography) was conducted in 53.9% of the patients. Subtype classification was made through a consensus approach based on the strict application of TOAST criteria. Results: The mean age of patients was 62 ± 12 years, and 60.8% were males. Undetermined cause (UD) was the most frequent subtype (40.6%), which was followed by lacunar stroke (LS 21.5%), cardiac embolism (CE 18.3%), large-artery atherosclerosis (LAA 16.5%) and other determined causes (3.1%). Hypertension was found in 64.3%, smoking in 35.2%, diabetes mellitus in 26.9%, hypercholesterolemia in 24.1%, high hematocrit (≧50%) in 21.8%, clinically identified potential cardiac sources of embolism in 18.3%, a history of previous stroke in 22.0% and a history of previous transient ischemic attack in 4.7%. Recurrent stroke was associated with a higher number of risk factors (p < 0.001) and a higher incidence of LAA (p = 0.003) than the first stroke. Vertebrobasilar artery territorial infarction was found in 39.8%, which was associated with higher incidences of LAA and LS and a lower incidence of CE than carotid artery territorial lesions (p = 0.001). The 30-day mortality rate was 5.3% and cerebral herniation caused early death in 52%. Conclusion: The distribution of stroke subtypes in the YSR was largely comparable with that of western registries. The highest incidence of UD might be related to the strict application of TOAST criteria.

Keywords:
Stroke registry, Cerebral infarction, Risk factor, Subtype classification
1.
Mohr JP: Stroke data banks (editorial). Stroke 1986;17:171–172.
2.
Caplan LR, Gorelick PB, Hier DB: Race, sex and occlusive cerebrovascular disease: A review. Stroke 1986;17:648–655.
3.
Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Daucan GW, Kistler JP, Pessin MS, Bleich HL: The Harvard cooperative stroke registry: A prospective registry. Neurology 1978;28:754–762.
4.
Chambers BR, Donnan GA, Bladin PF: Patterns of stroke: An analysis of the first 700 consecutive admissions to the Austin Hospital Stroke Unit. Aust NZ J Med 1983;13:57–64.
5.
Kunitz SC, Gross CR, Heyman A, Kase CS, Mohr JP, Price TR, Wolf PA: The pilot stroke data bank: Definition, design, and data. Stroke 1984;15:740–746.
6.
Gross CR, Kase CS, Mohr JP, Cunningham SC, Baker WE: Stroke in South Alabama: Incidence and diagnostic features – A population based study. Stroke 1984;15:249–255.
7.
Suzuki K, Kutsuzawa T, Takita K, Ito M, Sakamoto T, Hirayama A, Ito T, Ishida T, Ooish H, Kawakami K, Hirota K, Ogasawara T, Yoshida J, Tamura T, Hattori S, Iwabuchi S, Karouji Y, Waga T, Oosato Y, Yazaki Y, Saito T, Oouchi T, Kojima S: Clinico-epidemiologic study of stroke in Akita, Japan. Stroke 1987;18:402–406.
8.
Bogousslavsky J, Melle GV, Regli F: The Lausanne stroke registry: Analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083–1092.
9.
Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB: The stroke data bank: Design, methods, and baseline characteristics. Stroke 1988;19:547–554.
10.
Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Walf PA: Infarcts of undetermined cause: The NINCDS Stroke Data Bank. Ann Neurol 1989;25:382–390.
11.
Friday G, Lai SM, Alter M, Sobel E, LaRue L, Gil-Peralta A, McCoy RL, Levitt LP, Isack T: Stroke in the Lehigh Valley: Racial/ethnic differences. Neurology 1989;39:1165–1168.
12.
Kay R, Woo J, Kreel L, Wong HY, Tech R, Nicholls MG: Stroke subtypes among Chinese living in Hong Kong: The Shatin stroke registry. Neurology 1992;42:985–987.
13.
Rothrock JF, Lyden PD, Brody ML, Taft-Alvarez B, Kelly N, Mayer J, Wiedaholt WC: An analysis of ischemic stroke in an urban southern California population: The university of San Diego Stroke data bank. Arch Intern Med 1993;153:619–624.
14.
Del Brutto OH, Mosquera A, Sanchez X, Sautos J, Noboa CA: Stroke subtypes among Hispanics living in Guayaquil, Ecuador: Results from the Luis Vernaza Hospital stroke registry. Stroke 1993;24:1833–1836.
15.
Bornstein NM, Aronovich BD, Karepov VG, Gur AY, Treves TA, Oved M, Korczyn AD: The Tel Aviv stroke registry: 3,600 consecutive patients. Stroke 1996;27:1770–1773.
16.
Yip PK, Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, Chen RC: Subtypes of ischemic stroke: A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 1997;28:2507–2512.
17.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, March EE, and the TOAST investigators: Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. Stroke 1993;24:35–41.
18.
Damasio H: A computed tomographic guide to the identification of cerebral vascular territories. Arch Neurol 1983;40:132–142.
19.
Tatu L, Moulin T, Bogousslavsky J, Duvernoy H: Arterial territories of human brain: Brainstem and cerebellum. Neurology 1996;47:1125–1134.
20.
Pullicino PM: Diagrams of perforating artery territories in axial, coronal and sagittal planes. Adv Neurol 1992;62:41–72.
21.
Brust RW: Patterns of cerebrovascular disease in Japanese and other population groups in Hawaii: An angiographic study. Stroke 1975;6:539–542.
22.
Nishimaru K, McHenry LC, Toole JF: Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke 1984;15:56–59.
23.
Leung SY, Ng THK, Yuen ST, Lauder IJ, Ho FCS: Pattern of cerebral atherosclerosis in Hong Kong Chinese: Severity in intracranial and extracranial vessels. Stroke 1993;24:779–786.
24.
Liu HM, Tu YK, Yip PK, Su CT: Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: Preliminary experience. Stroke 1996;27:650–653.
25.
Li SC, Schoenberg BS, Wang CC, Cheng XM, Bolis CL, Wang KJ: Cerebrovascular disease in the People’s Republic of China: Epidemiologic and clinical features. Neurology 1985;35:1708–1713.
26.
Whisnant JP, Matsumoto N, Elveback LR: Transient cerebral ischemic attacks in a community, Rochester, MN, 1955 through 1969. Mayo Clin Proc 1973;48:194–198.
27.
Huang CY, Chan FL, Yu YL, Woo E, Chin D: Cerebrovascular disease in Hong Kong Chinese. Stroke 1990;21:230–235.
28.
Wolf PA, Cobb JL, D’Agostino RB: Epidemiology of stroke; in Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 2. New York, Churchill Livingstone, 1992, pp 3–27.
29.
Mohr JP, Barnett HJM: Classification of ischemic strokes; in Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 1. New York, Churchill Livingstone, 1986, pp 281–291.
30.
The Korean Neurological Association: Epidemiology of cerebrovascular disease in Korea. J Kor Med Sci 1993;8:281–289.
31.
Oh WS, Nam HS, Kim HS, Heo JH, Lee BI: Interobserver agreement of the diagnosis of subtypes of acute ischemic stroke in the TOAST classification and the pitfalls in its clinical application (abstract). Neurology 2000;54:127.
32.
Sacco RL, Benjamin EJ, Broderick JP, Dyken M, Easton D, Feinberg WM, Goldstein LB, Gorelick PB, Howard G, Kittner SJ, Manolio TA, Whisnant JP, Wolf PA: AHA conference proceedings: Risk factors. Stroke 1997;28:1507–1517.
33.
Sacco RL, Shi T, Zamanillo MC, Kargman DE: Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: The Northern Manhattan stroke study. Neurology 1994;44:626–634.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.